Aclarion (ACON) vs BioNexus Gene Lab (BGLC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Aclarion is the larger company by market cap ($3.5 million vs $2.0 million), about 1.8 times the size. BioNexus Gene Lab converts more of its revenue into profit, with a net margin of -40.2% versus -9551.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACON | BGLC |
|---|---|---|
| Share price | $1.22 | $0.68 |
| Market cap | $3.52M | $1.99M |
| 1-day change | -13.92% | 0.00% |
| EPS (TTM) | $-5.01 | $-1.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $75.73K | $7.42M |
| Revenue growth (YoY) | +65.62% | -21.93% |
| Net income (latest FY) | $-7.23M | $-2.98M |
| Gross margin | 9.02% | 14.62% |
| Operating margin | -9312.55% | -39.93% |
| Net margin | -9551.87% | -40.20% |
| 52-week high | $9.36 | $4.97 |
| 52-week low | $1.22 | $0.621 |
| Distance from 52-week high | -86.94% | -86.32% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +524.18% | — |
| Average volume | 34.73K | 6.70K |
| Shares outstanding | 2.88M | 2.93M |
| Employees | 10 | 19 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BioNexus Gene Lab is more profitable, keeping -40.2 cents of every revenue dollar as net income versus -9551.9 cents for Aclarion.
- Aclarion grew revenue faster in its latest fiscal year (+65.62% vs -21.93%).
About Aclarion
ACON stock →Aclarion, Inc. operates as a healthcare technology company in the United States.
Health Care · Medical Specialities · 10 employees
About BioNexus Gene Lab
BGLC stock →BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.
Health Care · Medical Specialities · 19 employees
ACON vs BGLC FAQ
Which is bigger, Aclarion or BioNexus Gene Lab?
Aclarion (ACON) is larger, with a market capitalization of $3.52M compared with $1.99M for BioNexus Gene Lab (BGLC).
Are Aclarion and BioNexus Gene Lab in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.